Huadong Medicine: 2023 Annual Environmental, Social, and Governance (ESG) Report (English Version)
Huadong Medicine: Announcement of resolutions from the 26th meeting of the 10th Board of Directors.
Huadong Medicine: Announcement of the resolutions of the 25th meeting of the 10th Board of Directors.
Huadong Medicine: Independent financial advisor report on the adjustment of repurchase price and repurchase cancellation of some restricted stocks in the 2022 restricted stock incentive plan of huadong medicine limited by GuoSheng Securities Co., Ltd.
Huadong Medicine: Announcement of Resolutions of the 16th Meeting of the 10th Board of Supervisors
Huadong Medicine: Independent Financial Advisory Report of Guosheng Securities Co., Ltd. on the 2022 Restricted Stock Incentive Plan of Huadong Pharmaceutical Co., Ltd. on the adjustment of repurchase prices and the repurchase and cancellation of some restricted stocks
Huadong Medicine: Announcement of Resolutions of the 24th Meeting of the 10th Board of Directors
Huadong Medicine: May 8, 2024 Investor Relations Activity Record Form (Investor Reception Day Event)
Huadong Medicine: Investor Relations Activity Schedule for April 30, 2024
Huadong Medicine: April 26, 2024 Investor Relations Activity Schedule
Huadong Medicine: Announcement of Resolutions of the 15th Meeting of the 10th Board of Supervisors
Huadong Medicine: Announcement of Resolutions of the 23rd Meeting of the 10th Board of Directors
Huadong Medicine: Announcement on holding an investor reception day event
Huadong Pharmaceutical: Announcement on holding an online performance briefing
Huadong Pharmaceutical: Investor Relations Activity Record Form for April 18, 2024
Huadong Pharmaceutical: 2023 Environmental, Social and Governance (ESG) Report
Huadong Pharmaceutical: Independent Director's 2023 Debriefing Report (Yang Lan)
Huadong Pharmaceutical: Evaluation Report on the Performance Status of Accounting Firms in 2023
Huadong Pharmaceutical: Independent Director's 2023 Debriefing Report (Gao Xiangdong)
Huadong Pharmaceutical: Independent Director's 2023 Debriefing Report (Huang Jian)
No Data